Longitude Capital
  • ABOUT
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • LP LOGIN
Select Page

Nalu PNS System achieves significant and durable pain reduction, meeting the primary endpoint of the COMFORT RCT study

by Carolyn Helms | Jun 4, 2024 | Portfolio News

Cohere Health, Medical Mutual, and Rhyme Partner on Utilization Management Transformation

by Carolyn Helms | Jun 4, 2024 | Portfolio News

Bolt Medical Announces Results of First 60 Patients in RESTORE ATK Pivotal Trial for the Unique Bolt Intravascular Lithotripsy System

by Carolyn Helms | May 29, 2024 | Portfolio News

Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)

by Carolyn Helms | May 28, 2024 | Portfolio News

New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis

by Carolyn Helms | May 19, 2024 | Portfolio News

« Older Entries
Next Entries »

Media Contact

Maggie Jamison

mjamison@longitudecapital.com

650-854-5700

  • Facebook
  • X
  • RSS
footer-logo

LP Login

© 2026 Longitude Capital. All rights reserved.
  • Privacy Policy
  • Disclaimer